MarkVCID brings team science approach to small vessel disease biomarkers in the brain. Read More
Rare diseases affect an estimated 25 million Americans. Read More
NIH-led trial to evaluate RSV vaccine’s safety in healthy adults. Read More
Hormone treatment improved bone strength and hemoglobin levels; may increase cardiovascular risk; had no effect on cognition. Read More
Earlier research found the vaccine to be safe, well-tolerated and protective for more than a year Read More
Experimental vaccine targets mosquito saliva. Read More
In 2015, 212 million cases of malaria occurred worldwide, and 429,000 people with malaria died. Read More
NIH-funded study also observes less neurological impairment among surviving infants. Read More
Research presents a new target for HIV prevention and treatment, and sheds light on how HIV develops. Read More
NIH-funded study also identifies potential new mechanism for some forms of epilepsy. Read More
